SCHEDULE 13G/AAccepted May 13, 1:00 PM ET
Aspire Biopharma Holdings, Inc. SCHEDULE 13G/A
Accepted (ET)
1:00 PM
May 13, 2026
Filed
May 13, 2026
Documents
3
Size
34.0 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.